Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392.SS)

CNY 75.33

(-0.49%)

Market Cap (In CNY)

95.24 Billion

Revenue (In CNY)

5.47 Billion

Net Income (In CNY)

1.24 Billion

Avg. Volume

2.96 Million

Currency
CNY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
47.62-89.89
PE
-
EPS
-
Beta Value
2.257
ISIN
CNE100004090
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Tao Yu
Employee Count
-
Website
https://www.ystwt.com
Ipo Date
2020-04-29
Details
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. researches, develops, produces, distributes, and sells infectious disease diagnostic reagents and vaccines in China and internationally. The company provides COVID 19, HIV and HTLV, Hepatitis, EV-71, and Tuberculosis diagnostics test kits; Hepatitis C and Syphilis detection reagents; automated immunoassays; ELISA kits and rapid tests for infectious disease diagnostics; chemiluminescence and clinical chemistry reagents; immunodiagnostic reagents; and Hepatitis E and human papillomavirus vaccines. It serves blood banks, hospitals and clinics, reference laboratories, border inspection centers, blood-processing companies, and research institutes. The company was founded in 1991 and is headquartered in Beijing, China.